Search

Your search keyword '"Lázaro Quintela, Martín"' showing total 30 results

Search Constraints

Start Over You searched for: Author "Lázaro Quintela, Martín" Remove constraint Author: "Lázaro Quintela, Martín"
30 results on '"Lázaro Quintela, Martín"'

Search Results

2. A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)

3. Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer

4. A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial

5. Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)

7. Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study

8. Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group

9. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

10. Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

11. Recent advances in genitourinary tumors: A review focused on biology and systemic treatment

12. Side Effects of Targeted Therapy

13. Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

14. Preferences for Renal Cell Carcinoma Pharmacological Treatment: A Discrete Choice Experiment in Patients and Oncologists

15. Measures to evaluate quality of care in renal cancer: results of a Delphi study in Spain

16. ECO Experts’ consensus on establishing renal cancer healthcare quality measures in Spain.

17. PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

18. Expert consensus on the development of quality care measures for kidney cancer in Spain.

20. A new scenario in metastatic renal cell carcinoma: a SOG‑GU consensus

21. Analysis of the relationship between ratio N/L and survival in lung cancer patients treated with immunotherapy.

22. Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience

23. Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor tyrosine kinase inhibitors: the necessity of repeated molecular analysis

24. Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia)

25. Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study

26. Enzalutamide: a new prostate cancer targeted therapy against the androgen receptor

27. Radium-223 dichloride: a new paradigm in the treatment of prostate cancer

28. Molecular basis of hypertension side effects induced by sunitinib

Catalog

Books, media, physical & digital resources